Patient Priorities for CLL Care
February 12, 2024
February 12, 2025
This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with CLL Society.
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.
- Physicians - maximum of .5 AMA PRA Category 1 Credit™
The educational design of this activity addresses the needs of community-based physicians and teams, including malignant hematologists or hematologic oncologists, medical oncologists, oncology nurses, nurse practitioners, physician assistants, nurses, and other members of the CLL care team.
As targeted therapies have become the standard of care in chronic lymphocytic leukemia (CLL), it is increasingly important to refine therapy selection based on risk stratification. An in-depth analysis of community-based CLL practice patterns, registry data, and clinical guidelines can provide a benchmark for your own practice. Does your practice align with current evidence?
Hear from expert clinicians, Dr. Matthew Davids and Dr. Nicole Lamanna, as they explore current data and the patient and care-team factors that influence selection of therapy for CLL in the community setting. The panel will provide practical strategies to apply in your practice; which may can include improving timely testing, documentation, risk-stratification, treatment selection, and CLL management. Walk away with ready-to-implement actions to improve your team’s management of newly diagnosed and relapsed/refractory CLL.
After completing this activity, the participant should be better able to:
- Compare and contrast efficacy and safety data for guideline-recommended therapy options in the frontline and relapsed/recurrent settings
- Integrate targeted therapy into point-of-care decisions for patients with CLL
- Evaluate real-world patient-provider data to align on therapeutic goals, guideline-adherent practices, and delivery of quality care
Matthew S. Davids, MD, MMSc
Associate Professor of Medicine
Director of Clinical Research, Division of Lymphoma
Harvard Medical School
Dana-Farber Cancer Institute
Nicole Lamanna, MD
Professor of Medicine
Director of Chronic Lymphocytic Leukemia Program
Herbert Irving Comprehensive Cancer Center
Columbia University Medical Center/New York-Presbyterian
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statment
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 medical knowledge MOC point(s) in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosures of Relevant Financial Relationship(s)
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
The planners and managers at PlatformQ Health Education have no relevant financial relationships to disclose.
Instruction for Participaton and Credit:
Estimated Time to Complete
This activity should take approximately 30 minutes to complete.
Instruction to Receive Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.
Course Viewing Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Physician Accreditation Support:
For information about the physician accreditation of this program, please contact Global at 303-395-1782 or [email protected].
For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at [email protected].
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at [email protected]
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting [email protected] with the subject line “Data Request”